Godavari Biorefineries files DRHP with SEBI to raise Rs. 325 crore via fresh issue
General

Godavari Biorefineries files DRHP with SEBI to raise Rs. 325 crore via fresh issue

The total issue comprises of fresh issue of equity share aggregating up to Rs. 325 crore

  • By ICN Bureau | June 17, 2024

Godavari Biorefineries Limited (GBL), one of the prominent manufacturers of ethanol based chemicals in India, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).

As on March 31, 2024, GBL has the largest integrated bio-refinery in India in terms of installed capacity and were also the largest manufacturer of MPO (3 Methyl-3 Penten-2-One) worldwide in terms of installed capacity, one of only two manufacturers of natural 1, 3 butylene glycol and the only company in India to manufacture bio ethyl acetate according to Frost & Sullivan Report.

The company plans to raise fund through Equity Share Capital of face value Rs. 10 each. The total issue comprises of fresh issue of equity share aggregating up to Rs. 325 crore and offer for sale of up to 65.27 lakh Equity Shares.

The company plans to utilized the net proceeds from fresh issue towards funding (i) Repayment/pre-payment, in full or in part, of certain outstanding borrowings availed by the company amounting to Rs. 240 crore and balance amount towards general corporate purpose.

The Offer for Sale comprises of up to 4,926,983 Equity Share by Mandala Capital AG Limited [Investor Selling Shareholders], up to 500,000 Equity Shares by Somaiya Agencies Private Limited, up to 2,00,000 Equity Shares by Samir Shantilal Somaiya, up to 200,000 Equity Shares by Lakshmiwadi Mines and Minerals Private Limited  [Promoter Selling Shareholders],  up to 300,000 Equity Shares by Filmedia Communication Systems Private Limited, up to 100,000 Equity Shares by Somaiya Properties and Investments Private Limited [Promoter Group Selling Shareholders].

Equirus Capital Private Limited and SBI Capital Markets Limited are the Book Running Lead Managers to the IPO.

According to Frost & Sullivan Report the Company has set up India’s first bio-based EVE (Ethyl Vinyl Ethers) manufacturing facility in India as on March 31, 2024 and is poised to capitalize on the import substitution opportunity for EVE in India.

The India market size for the EVE market was approximately 1,258 MT in 2023.  Looking forward, the market is expected to grow at a CAGR of 10.0%, reaching to 2,026 MT by 2028. The rise in demand was driven by growing demand from the pharmaceuticals & agrochemicals sector.

Register Now to Attend Navigating the Path to Net-zero in the Chemicals Industry on Friday, 26 July 2024

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization